| A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A K Spencer, V Souter, N Tul, R Snijders, KH Nicolaides Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 1999 | 810 | 1999 |
| Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk‐orientated two‐stage … KH Nicolaides, K Spencer, K Avgidou, S Faiola, O Falcon Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2005 | 657 | 2005 |
| First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications CYT Ong, AW Liao, K Spencer, S Munim, KH Nicolaides BJOG: An International Journal of Obstetrics & Gynaecology 107 (10), 1265-1270, 2000 | 544 | 2000 |
| Analytical reviews in clinical biochemistry: the estimation of creatinine K Spencer Annals of clinical biochemistry 23 (1), 1-25, 1986 | 498 | 1986 |
| Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience K Spencer, CE Spencer, M Power, C Dawson, KH Nicolaides BJOG: an international journal of obstetrics and gynaecology 110 (3), 281-286, 2003 | 485 | 2003 |
| One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies R Bindra, V Heath, A Liao, K Spencer, KH Nicolaides Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2002 | 400 | 2002 |
| Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery Doppler K Spencer, CKH Yu, NJ Cowans, C Otigbah, KH Nicolaides Prenatal Diagnosis: Published in Affiliation With the International Society …, 2005 | 358 | 2005 |
| First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: impact of maternal and pregnancy characteristics KO Kagan, D Wright, K Spencer, FS Molina, KH Nicolaides Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2008 | 357 | 2008 |
| Low levels of maternal serum PAPP‐A in the first trimester and the risk of pre‐eclampsia K Spencer, NJ Cowans, KH Nicolaides Prenatal Diagnosis: Published in Affiliation With the International Society …, 2008 | 340 | 2008 |
| Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis P Benn, A Borrell, RWK Chiu, H Cuckle, L Dugoff, B Faas, S Gross, ... Prenatal diagnosis 35 (8), 725-734, 2015 | 332 | 2015 |
| First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐eclampsia K Spencer, NJ Cowans, I Chefetz, J Tal, H Meiri Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2007 | 330 | 2007 |
| Screening for trisomy 13 by fetal nuchal translucency and maternal serum free β‐hCG and PAPP‐A at 10–14 weeks of gestation K Spencer, C Ong, H Skentou, A W. Liao, K H. Nicolaides Prenatal Diagnosis: Published in Affiliation With the International Society …, 2000 | 289* | 2000 |
| Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis P Benn, A Borell, R Chiu, H Cuckle, L Dugoff, B Faas, S Gross, J Johnson, ... Prenatal diagnosis 33 (7), 622-629, 2013 | 276 | 2013 |
| One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester K Spencer, CE Spencer, M Power, A Moakes, KH Nicolaides BJOG: An International Journal of Obstetrics & Gynaecology 107 (10), 1271-1275, 2000 | 257 | 2000 |
| Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β‐hCG and PAPP‐A at 11 to 14 weeks S Cicero, R Bindra, G Rembouskos, K Spencer, KH Nicolaides Prenatal Diagnosis: Published in Affiliation With the International Society …, 2003 | 241 | 2003 |
| First‐trimester biochemical markers of aneuploidy and the prediction of small‐for‐gestational age fetuses K Spencer, NJ Cowans, K Avgidou, F Molina, KH Nicolaides Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2008 | 238 | 2008 |
| Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies K Avgidou, A Papageorghiou, R Bindra, K Spencer, KH Nicolaides American journal of obstetrics and gynecology 192 (6), 1761-1767, 2005 | 232 | 2005 |
| Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers K Spencer, EJ Coombes, AS Mallard, AM Ward Annals of clinical biochemistry 29 (5), 506-518, 1992 | 223 | 1992 |
| First‐trimester ADAM12 and PAPP‐A as markers for intrauterine fetal growth restriction through their roles in the insulin‐like growth factor system NJ Cowans, K Spencer Prenatal Diagnosis: Published in Affiliation with the International Society …, 2007 | 221 | 2007 |
| Predicting complications of pregnancy with first‐trimester maternal serum free‐βhCG, PAPP‐A and inhibin‐A N Tul, S Pušenjak, J Osredkar, K Spencer, Ž Novak‐Antolič Prenatal Diagnosis: Published in Affiliation with the International Society …, 2003 | 209 | 2003 |
